drugset / Trial / NCT02087397
Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction
NaSingle-groupOpen-labelTreatment
Summary
This will be an open-label, non-randomized, multi-center, patient sponsored study of Adipose-Derived Stromal Vascular Fraction cells (AD-SVF) implantation delivered into the corpus cavernous in patients with Erectile Dysfunction. The intent of this clinical study is to answer the questions: 1) Is the proposed treatment safe and 2) Is treatment effective in improving the disease pathology of patients with diagnosed Erectile Dysfunction.
Timeline
- Start
- 2014-03
- Primary completion
- 2017-11
- Completion
- 2017-12
Outcome
Outcome not reported
Stopped: “company dissolved”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-SVF | Cell therapy | — | Other |